News

Will This Drug Relight the Dimming Hope of Finding Effective Therapies for COVID-19?

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate…

Read more

Can Vaccines Win the Race Against the Novel Coronavirus?

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather,…

Read more

Don’t Ignore These Ovarian Cancer Related Symptoms

Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed…

Read more

Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed…

Read more

AACR Virtual Annual Meeting I presents new data on cancer biology, treatment, screening, risk reduction

Brief points covered in the America Association for Cancer Research (AACR) Virtual Annual Meeting I held on April 27-28th: -Treating BRAF-Positive Melanoma by adding checkpoint inhibitor Tecentriq (atezolizumab) to a combination of two targeted drugs…

Read more